Time sequential expression of markers of apoptosis induced by 1-β-D-arabinofuranosylcytosine in human T-Lymphoblastic leukemia CCRF-CEM cells

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1987-1995

  Badran, A ^a   Iwasaki, H ^a   Wano, Y ^a   Kishi, S ^a   Ueda, T ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

APO 2.7; Apoptosis; High molecular weight DNA fragmentation; Phosphatidylserine; TUNEL assay

Indexed keywords

ANTIINFECTIVE AGENT; CYTARABINE; DNA FRAGMENT; HYDROXYL GROUP; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL SEPARATION; CYTARABINE; DNA FRAGMENTATION; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; KINETICS; LEUKEMIA, LYMPHOCYTIC; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034898755     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Apoptosis: Cell death in tissue regulation
2. Mechanisms and functions of cell death
3. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
4. Apoptosis in the pathogenesis and treatment of disease
5. The shape of cell death
6. Apoptosis and the dilemma of cancer chemotherapy
7. A license to kill
8. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
9. Induction of apoptosis by the antitubulin drug Colcemid: Relationship of mitotic check-point control to the induction of apoptosis in Hela S3 cells
10. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
11. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
12. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
13. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
14. Caspase 3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo
15. Proteolytic cleavage during chemotherapy-induced apoptosis
16. Protease activation during apoptosis: Death by a thousand cuts?
17. Specific proteolytic cleavage of poly (ADP- ribose) polymerase: An early marker of chemotherapy-induced apoptosis
18. Specific cleavage of the 70-KDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death
19. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
20. Proteolysis of fordin (Non-erythroid spectrin) during apoptosis
21. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution
22. Sequential activation of three distinct ICE-like activities in Fasligated Jurkat cells
23. DNA damage and cell killing by camtothecin and its derivative in human leukemia HL-60 cells
24. Apoptosis: Its significance in cancer and cancer therapy
25. Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes
26. Clinical pharmacology of 1-β-D-Arabinofuranosylcytosine-5′-stearylphosphate, an orally administered long-acting derivative of low-dose 1-β-D-Arabino furanosylcytosine
27. Differential incorporation of Ara-C, Gemcitabine and Fludarabine into replicating and repairing DNA in proliferating human leukemia cells
28. Flowcytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
29. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells
30. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO 2.7
31. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of bcl2 and abl
32. Transverse redistribution of phospholipids during human platelet activation: Evidence for a vectorial outflux specific to aminophospholipids
33. Activation of programmed cell death (Apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
34. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells
35. Mg(2+)-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis
36. High molecular weight DNA fragmentation: A critical event in nucleoside analogue-induced apoptosis in leukemia cells
37. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug induced apoptosis
38. Plasma membrane alterations and cytoskeletal changes in apoptosis
39. Multiple systems for recognition of apoptotic lymphocytes by macrophages
40. Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes
41. N-ethylmaleimide-enhanced phosphat idylserine externalization of human pancreatic cancer cells and immediate phosphatidylserine-mediated phagocytosis by macrophages
42. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages
43. Phosphatidylserine externalization is a downstream event of interleukin-1β-converting enzyme family protease activation during apoptosis
44. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
45. The proto-oncogene Bcl-2 and its role in regulating apoptosis
46. Mitochondrial control of nuclear apoptosis
47. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
48. Simultaneous determination of cell surface antigens and apoptosis
49. Programmed death of T cells in HIV-1 infection
50. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease
51. Defective apoptosis signal transduction pathway down stream of caspase-3 in human-B-lymphoma cells: A novel mechanism of nuclear apoptosis resistance